Key Takeaways on the Ruling Declaring the Affordable Care Act Unconstitutional
Avalere experts discuss the implications for a recent decision ruling the Affordable Care Act is Unconstitutional.
Lack of Clarity on Preventive Services Recommendations May Create Access Barriers
Ambiguous recommendations for preventive services are causing confusion among plans and providers on the clinically recommended preventive services that should be covered without cost sharing. A recent USPSTF recommendation on HIV prevention offers an opportunity to urge a recommending body to provide further clarity in its recommendation. Comments are due December 26.
Avalere Joins Core Quality Measures Collaborative
Avalere is excited to join the CQMC as quality measurement experts in an effort to further inform a discussion focused on core measure sets to assess the quality of American healthcare.
E2 – 8 Rules for Implementing New Medicare Advantage Supplemental Benefits
Check out the second interview in our series on new supplemental benefits offered through Medicare Advantage plans for 2019; Kenny Kan and Erica Breese discuss the "rule of 8."
Out-of-Pocket Costs for Oncology Drugs Vary Substantially Between Employer and Non-Employer Based Part D Plans
New Avalere analysis finds that beneficiaries enrolled in Employer Group Waiver Plans (EGWPs) have lower out-of-pocket (OOP) costs for select drugs than beneficiaries enrolled in other types of Part D plans.
Post-Election, Part B Drug Reform Is Likely to Advance
Avalere analysis finds that most of the payment reductions from the proposed International Pricing Index Model for Part B drugs would affect oncologists, rheumatologists, and ophthalmologists.
Actionable Resources to Facilitate Cost Conversations Between Patients and Clinicians
As part of the Robert Wood Johnson Foundation Cost Conversation projects, Avalere led the development of a set of practice briefs that provide actionable resources to healthcare providers about how to improve the value and frequency of cost conversations with patients.
Improving Malnutrition Care Quality to Support Better Patient Outcomes
Over the past several years, Avalere has collaborated with the Academy of Nutrition and Dietetics to establish and support the Malnutrition Quality Improvement Initiative (MQii).
E3 – Trends in Health Policy and the Mid-Term Elections Results
In the last interview of our mid-term elections series, Avalere experts Chris Sloan and Elizabeth Carpenter discuss potential implications on health policy.
E2 – Key Mid-Term Elections Driving Medicaid Expansion to Watch
Avalere experts, Chris Sloan and Tiernan Meyer, discuss potential state and federal-level scenarios for Medicaid expansion.
E1 – Impacts the Mid-Term Elections Could Have on Pre-Existing Conditions
In the first interview in our 3-part series covering the mid-term elections and potential implications on health policy, Avalere expert Chris Sloan explores potential implications of the mid-term elections on health policy. To kick off the series, Avalere Founder, Dan Mendelson, discusses pre-existing conditions.
Access to Abuse-Deterrent Opioid Formulations Tied to Reduced Risk of Opioid Abuse and Overdose
New Avalere research finds that health plan members enrolled in plans that cover abuse-deterrent formulations (ADFs) of opioids have a lower risk of opioid abuse (OA) and overdose (OD) and lower opioid abuse-related hospitalizations than people in plans that do not offer coverage of ADF opioids.
Trends in Opioid Use: History, Background, and Origins of the Epidemic
Shift in clinical practice as far back as 30 years ago planted the seeds for the current opioid epidemic. New research by Avalere Health finds that between the mid-1980s and 1990s, individual pharmaceutical manufacturers, national scientific bodies, and professional societies began a push to treat pain more aggressively.
2.7 Million People Could Gain Access to Medicaid Coverage Based on Outlook for State Elections
New analysis from Avalere finds that 2.7 million individuals from states that have not expanded Medicaid could gain Medicaid coverage should their newly elected governors decide to expand the program or states pass expansion referenda on their ballots.
Drug Pricing Policy: What’s on the Horizon?
Avalere experts examine the current drug pricing policy landscape and what potential changes stakeholders should prepare for.
E1 – New Supplemental Benefits Offered Through Medicare Advantage Plans
In episode 1 of our series Fred Bentley, Sean Creighton, and Kenny Kan discuss the new supplemental benefits offered through Medicare Advantage plans for 2019.
The Data Behind Social Determinants of Health Research
New Avalere study entitled “Using Aggregate Data to Proxy Individual-Level Socioeconomic Characteristics in Research on Medication Adherence: 9-Digit ZIP Code vs. Census Block Group” selected for the AMCP Foundation Best Poster Award at AMCP Nexus 2018.
CMS HCC Risk Adjustment Model 2019: Winners & Losers
Our analysis finds there will be winners and losers at the plan level under the new models.
Avalere Observations: 2018 Election Cycle and the Outlook for Health Policy
With the 2018 mid-term elections weeks away, polls show healthcare is a top issue on the minds of voters.
CMS 2019 Star Ratings Remain Stable for MA-PD Plans, Shift for PDPs
Join Avalere experts for our analysis of CMS’ 2019 Star Ratings and a look at what’s to come for 2020 on our webinar on November 1, 2018.